Related Experiment Videos

Overexpression of metallothionein reduces diabetic cardiomyopathy

Qiangrong Liang1, Edward C Carlson, Rajakumar V Donthi

  • 1Division of Molecular Cardiovascular Biology, University of Cincinnati, Ohio, USA.

Diabetes
|January 5, 2002
PubMed

Insights

Diabetic cardiomyopathy, a precursor to heart failure, can be mitigated by antioxidant proteins. Overexpressing metallothionein (MT) in diabetic mouse hearts reduced oxidative stress and improved cardiac function, demonstrating its protective effects.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic cardiomyopathy is a significant complication in diabetes mellitus, increasing the risk of heart failure and mortality.
  • Oxidative stress, indicated by elevated oxidized glutathione (GSSG), is implicated in the pathogenesis of diabetic cardiomyopathy.
  • Metallothionein (MT) is an antioxidant protein with potential protective roles in cardiac conditions.

Purpose of the Study:

  • To investigate the efficacy of cardiac-specific overexpression of the antioxidant protein metallothionein (MT) in ameliorating diabetic cardiomyopathy.
  • To determine if elevated MT levels can counteract oxidative stress and improve cardiac function in a mouse model of diabetes.

Main Methods:

  • Utilized OVE26 transgenic mice, a model for type 1 diabetes, and crossed them with MT-overexpressing transgenic mice to create OVE26MT mice.
  • Assessed cardiac function, morphology, mRNA expression, and levels of oxidized glutathione (GSSG) in diabetic (OVE26) and OVE26MT mice.
  • Compared OVE26MT mice with OVE26 mice, noting similar hyperglycemia levels between the groups.

Main Results:

  • Diabetic OVE26 mice exhibited characteristic cardiomyopathy, including altered mRNA, morphological abnormalities, and impaired contractility under ischemia.
  • OVE26MT mice, despite having similar hyperglycemia, showed significantly reduced cardiomyopathy compared to OVE26 mice.
  • Elevated cardiac MT in OVE26MT mice normalized mRNA levels, reduced GSSG, preserved normal heart morphology, and improved impaired ischemic contractility.

Conclusions:

  • Cardiomyocyte-specific expression of the antioxidant protein metallothionein (MT) effectively reduces cardiac damage in a mouse model of diabetes.
  • Targeting oxidative stress through antioxidant protein overexpression represents a promising therapeutic strategy for diabetic cardiomyopathy.
  • These findings highlight the protective role of MT against diabetes-induced cardiac dysfunction.

Related Concept Videos